Prosaposin is a novel androgen-regulated gene in prostate cancer cell line LNCaP

Journal of Cellular Biochemistry

Volumn 101, Issue 3, 2007, Pages 631-641

  Koochekpour, S ^a,b   Lee, T J ^a   Wang, R ^c   Sun, Y ^d   Delorme, N ^a   Hiraiwa, M ^e   Grabowski, G A ^d   Culig, Z ^f   Minokadeh, A ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

AR; HRE; Prosaposin promoter; Prostate; PSA

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; GROWTH FACTOR; PROSAPOSIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; PLEIOTROPY; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR OCCUPANCY;

ANDROGENS; BLOTTING, WESTERN; CELL LINE, TUMOR; DIHYDROTESTOSTERONE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; LUCIFERASES; MALE; PLASMIDS; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; PROTEIN BINDING; RECEPTORS, ANDROGEN; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAPOSINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 34247897068     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21207     Document Type: Article

References (35)

1. Arnold JT, Isaacs JT. 2002. Mechanisms involved in the progression of androgen-independent prostate cancers: It is not only the cancer cell's fault. Endocr Relat Cancer 9:61-73.
2. Bohl CE, Gao W, Miller DD, Bell CE, Dalton JT. 2005. Structural basis for antagonism and resistance of bicalutamide in prostate cancer. Proc Natl Acad Sci USA 102: 6201-6206.
3. Cato AC, Henderson D, Ponta H. 1987. The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region. EMBO J 6:363-368.
4. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H. 1994. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54:5474-5478.
5. Culig Z, Hoffmann J, Erdel M, Eder IE, Hobisch A, Hittmair A, Bartsch G, Utermann G, Schneider MR, Parczyk K, Klocker H. 1999. Switch from antagonist of the androgen receptor bicalutamide is associated with prostate tomour progression in a new model system. Br J Cancer 81:242-251.
6. Culig Z, Klocker H, Bartsch G, Hobisch A. 2001. Androgen receptor mutations in carcinoma of the prostate: Significance for endocrine therapy. Am J Pharmacogenomics 1:241-249.
7. Denison SH, Sands A, Tindhall DJ. 1989. A tyrosine aminotransferase glucocorticoid response element also mediates androgen enhancement of gene expression. Endocrinology 124:1091-1093.
8. Feldman BJ, Feldman D. 2001. The development of androgen-independent prostate cancer. Nat Rev Cancer 1:34-45.
9. Ham J, Thomson A, Needham M, Webb P, Parker M. 1988. Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. Nucleic Acids Res 24:5263-5276.
10. Hara T, Miyazaki J, Araki H, Yamaoka M, Kanjaki N, Kusaka M, Miyamoto M. 2003. Novel mutations of androgen receptor: A possible mechanism of bicalutamide withdrawal syndrome. Cancer Res 63:149-153.
11. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. 2005. Cancer Statistics. CA Cancer J Clin 55:10-30.
12. Jenster G. 1999. The role of the androgen receptor in the development and progression of prostate cancer. Semin Oncol 26:407-421.
13. Jung M, Romer A, Keyszer G, Lein M, Kristiansen G, Schnorr D, Loening SA, Jung Klaus. 2003. mRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down- regulation in human malignant prostatic tissue. Prostate 55:89-98.
14. Kelly WK, Slovin S, Scher HI. 1997. Steroid hormone withdrawal syndromes. Pathophysiology and clinical significance. Urol Clin North Am 24:421-431.
15. Kishimoto Y, Hiraiwa M, O'Brien JS. 1992. Saposins: Structure, function, distribution and molecular genetics. J Lipid Res 33:1255-1267.
16. Koochekpour S. 2006a. PSAP (Prosaposin (variant Gaucher disease and variant metachromatic leukodystrophy)). Atlas Genet Cytogenet Oncol Haematol. URL:http://www. infobiogen.fr/services/chromcancer/Genes/ PSAPID42980 ch10q22.html.
17. Koochekpour S, Sartor O, Lee TJ, Zieske AJ, Patten DY, Hiraiwa M, Sandhoff K, Remmel N, Minokadeh A. 2004a. Prosaptide TX14A stimulates growth, migration, and invasion and activates the Raf-MEK-ERK-RSK-Elk-1 signaling pathway in prostate cancer cells. Prostate 61: 114-123.
18. Koochekpour S, Maresh A, Katner A, Parker-Johnson K, Lee TJ, Hebert FE, Kao YS, Skinner J, Rayford W. 2004b. Establishment and characterization of a primary androgen-responsive African-American prostate cancer cell line, E006AA. Prostate 60:141-152.
19. Koochekpour S, Sartor O, Hiraiwa M, Lee TJ, Rayford W, Remmel N, Sandhoff K, Minokadeh A, Patten DY. 2005a. Saposin C stimulates growth and invasion, activates p42/ 44 and SAPK/JNK signaling pathways of MAPK and Upregulates uPA/uPAR expression in prostate cancer and stromal cells. Asian J Androl 7:147-158.
20. Koochekpour S, Zhuang YJ, Beroukhim R, Hsieh CL, Hofer MD, Zhau HE, Hiraiwa M, Pattan DY, Ware JL, Luftig RB, Sandhoff K, Sawyers CL, Pienta KJ. 2005b. Amplification and overexpression of prosaposin in prostate cancer. Genes Chromosomes Cancer 44:351-364.
21. Koochekpour S, Lee TJ, Wang R, Culig Z, Delorme N, Caffey S, Marrero L, Aguirre J. 2006b. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP). Prostate (in press).
22. Lee TJ, Sartor O, Luftig R, Koochekpour S. 2004. Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells. Mol Cancer 3:31.
23. Martin JL, Pattison SL. 2000. Insulin-like growth factor binding protein-3 is regulated by dihydrotestosterone and stimulate deoxyribonucleic acid synthesis and cell proliferation in LNCaP prostate carcinoma cells. Endocrinology 141:2401-2409.
24. Morales CR, Zhao Q, El-Alfy M, Suzuki K. 2000. Targeted disruption of the mouse prosaposin gene affects the development of the prostate gland and other male reproductive organs. J Androl 21:765-775.
25. Morin B, Zhu C, Woodcock GR. 2000. The binding site for Xenopus glucocorticoid receptor accessory factor and a single adjacent half-GRE form an independent glucocorticoid response unit. Biochemistry 39:12234-12242.
26. O'Brien JS, Carson GS, Seo HC, Hiraiwa M, Kishimoto Y. 1994. Identification of prosaposin as a neurotrophic factor. Proc Natl Acad Sci USA 91:9593-9596.
27. Parker MG, Webb P, Mills JS, Needham M, White R. 1988. Analysis of regulatory sequences in androgen-responsive genes. J Steroid Biochem 30:47-51.
28. Rennie PS, Bruchovsky N, Leco KJ, Sheppard PC, McQueen SA, Cheng H, Snoek R, Hamel A, Bock ME, MacDonald BS. 1993. Characterization of two Cis-acting DNA elements involved in the androgen regulation of the Probasin gene. Mol Endocrinol 7:23-36.
29. Sella A, Flex D, Sulkes A, Baniel J. 2004. Antiandrogen withdrawal syndrome with cyproterone acetate. Urology 52:1091-1093.
30. Simon AM, Veyssiere G, Jean C. 1995. Structure and sequence of a mouse gene encoding an androgen-regulated protein: A new member of the seminal vesicle secretory protein family. J Mol Endocrinol 15:305-306.
31. Sordello S, Bertrand N, Plouet J. 1998. Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens. Biochem Biophys Res Commum 251:287-290.
32. Strahle U, Klock G, Schultz GA. 1987. A DNA sequence of 15 base pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression. Proc Natl Acad Sci USA 84:7871-7875.
33. Sun Y, Jin P, Witte DP, Grabowski GA. 1998. Isolation and characterization of the human prosaposin promoter. Gene 218:37-47.
34. Suzuki H, Akakura K, Komiya A, Aida S, Akimoto S, Shimazaki J. 1996. Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: Relation to antiandrogen withdrawal syndrome. Prostate 29:153-158.
35. Yeung F, Li X, Ellett J, Trapman J, Kao C, Chung LW. 2000. Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells. J Biol Chem 275:40846-40855.